CVE-2025-55341
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php...
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php asocImgRad.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php asocImgRad.
- Record
CVE-2025-55341- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
EUVDEUVD-2025-37925
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php asocImgRad.
- Record
EUVD-2025-37925- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-8f5r-v3mh-q89r
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php...
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php asocImgRad.
- Record
GHSA-8f5r-v3mh-q89r- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD
Cross Site Scripting vulnerability in Quipux 4.0.1 through e1774ac allows anexos/anexos_nuevo.php asocImgRad.
- Record
CVE-2025-55341- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-05
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| facts | NVD | |
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-55341 is a medium vulnerability (CVSS 6.5) in Quipux, published November 5, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.22%, the 12th percentile. No source names a fixed version.